Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21


An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.

Lee BY, Bartsch SM, Mvundura M, Jarrahian C, Zapf KM, Marinan K, Wateska AR, Snyder B, Swaminathan S, Jacoby E, Norman JJ, Prausnitz MR, Zehrung D.

Vaccine. 2015 Sep 8;33(37):4727-36. doi: 10.1016/j.vaccine.2015.02.076. Epub 2015 Mar 13.


Evaluation of a new, rapid, simple test for the detection of influenza virus.

Hurtado JC, Mosquera MM, de Lazzari E, Martínez E, Torner N, Isanta R, de Molina P, Pumarola T, Marcos MA, Estape JV.

BMC Infect Dis. 2015 Feb 6;15:44. doi: 10.1186/s12879-015-0775-5.


Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.

You JH, Ming WK, Chan PK.

BMC Infect Dis. 2014 Nov 25;14:618. doi: 10.1186/s12879-014-0618-9.


Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States.

Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ.

BMC Public Health. 2014 Jul 15;14:718. doi: 10.1186/1471-2458-14-718.


Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.

Grzesiowski P, Aguiar-Ibáñez R, Kobryń A, Durand L, Puig PE.

Hum Vaccin Immunother. 2012 Oct;8(10):1382-94. doi: 10.4161/hv.21571. Epub 2012 Oct 1.


The potential economic value of a 'universal' (multi-year) influenza vaccine.

Lee BY, Tai JH, McGlone SM, Bailey RR, Wateska AR, Zimmer SM, Zimmerman RK, Wagner MM.

Influenza Other Respir Viruses. 2012 May;6(3):167-75. doi: 10.1111/j.1750-2659.2011.00288.x. Epub 2011 Sep 21.


Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patients.

Lee BY, Stalter RM, Bacon KM, Tai JH, Bailey RR, Zimmer SM, Wagner MM.

Am J Kidney Dis. 2011 May;57(5):724-32. doi: 10.1053/j.ajkd.2010.12.016. Epub 2011 Mar 10.


From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.

Lee BY, Bacon KM, Donohue JM, Wiringa AE, Bailey RR, Zimmerman RK.

Vaccine. 2011 Mar 3;29(11):2149-58. doi: 10.1016/j.vaccine.2010.12.078. Epub 2011 Jan 6.


To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling.

Lee BY, McGlone SM, Bailey RR, Wiringa AE, Zimmer SM, Smith KJ, Zimmerman RK.

PLoS One. 2010 Jun 23;5(6):e11284. doi: 10.1371/journal.pone.0011284.


The potential economic value of a Staphylococcus aureus vaccine for neonates.

Lee BY, Ufberg PJ, Bailey RR, Wiringa AE, Smith KJ, Nowalk AJ, Higgins C, Wateska AR, Muder RR.

Vaccine. 2010 Jun 23;28(29):4653-60. doi: 10.1016/j.vaccine.2010.04.069. Epub 2010 May 14.


Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis.

Lee BY, Bailey RR, Smith KJ, Muder RR, Strotmeyer ES, Lewis GJ, Ufberg PJ, Song Y, Harrison LH.

Infect Control Hosp Epidemiol. 2010 Jun;31(6):598-606. doi: 10.1086/652524.


Economics of influenza vaccine administration timing for children.

Lee BY, Tai JH, Bailey RR, Smith KJ, Nowalk AJ.

Am J Manag Care. 2010 Mar;16(3):e75-e85.


Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model.

Lee BY, Bailey RR, Wiringa AE, Assi TM, Beigi RH.

Obstet Gynecol. 2009 Nov;114(5):971-80. doi: 10.1097/AOG.0b013e3181bdbfed.


Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: clinical and economic impact.

Deuffic-Burban S, Lenne X, Dervaux B, Julien Poissy, Lemaire X, Sloan C, Carrat F, Desenclos JC, Delfraissy JF, Yazdanpanah Y.

PLoS Curr. 2009 Oct 26;1:RRN1121.


Economic value of seasonal and pandemic influenza vaccination during pregnancy.

Beigi RH, Wiringa AE, Bailey RR, Assi TM, Lee BY.

Clin Infect Dis. 2009 Dec 15;49(12):1784-92. doi: 10.1086/649013.


Economic evaluations of neuraminidase inhibitors to control influenza.

Schwarzinger M, Lacombe K, Carrat F.

Expert Rev Pharmacoecon Outcomes Res. 2003 Apr;3(2):147-58. doi: 10.1586/14737167.3.2.147.


The timing of influenza vaccination for older adults (65 years and older).

Lee BY, Tai JH, Bailey RR, Smith KJ.

Vaccine. 2009 Nov 23;27(50):7110-5. doi: 10.1016/j.vaccine.2009.09.056. Epub 2009 Sep 26.


A predictive model of the economic effects of an influenza vaccine adjuvant for the older adult (age 65 and over) population.

Lee BY, Ercius AK, Smith KJ.

Vaccine. 2009 Apr 6;27(16):2251-7. doi: 10.1016/j.vaccine.2009.02.024. Epub 2009 Feb 13.


The impact of economic evaluation on quality management in spine surgery.

Boos N.

Eur Spine J. 2009 Aug;18 Suppl 3:338-47. doi: 10.1007/s00586-009-0939-3. Epub 2009 Apr 1. Review.


Do pediatricians manage influenza differently than internists?

Rothberg MB, Bonner AB, Rajab MH, Stechenberg BW, Rose DN.

BMC Pediatr. 2008 Apr 24;8:15. doi: 10.1186/1471-2431-8-15.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk